NI-RADS | Recurrence | Fisher’s exact test | Cramér’s (V) | Linear by linear association | ||||
---|---|---|---|---|---|---|---|---|
Positive recurrence (PPV%) | Negative recurrence rate (NPV%) | Value | P | Value | P | Value | P | |
Primary lesion | Â | Â | 12.31 | 0.002 | 0.689 | 0.001 | 10.6 | 0.001 |
 NI-RADS 1 | 1/10 (10%) | 9/10 (90%) |  |  |  |  |  |  |
 NI-RADS 2 | 2/10 (20%) | 8/10 (80%) |  |  |  |  |  |  |
 NI-RADS 3 | 7/8 (87.5%) | 1/8 (12.5%) |  |  |  |  |  |  |
Total | 10/28 (35.7%) | 18/28 (64.3%) | Â | Â | Â | Â | Â | Â |
LN lesion | Â | Â | Â | Â | Â | Â | Â | Â |
 NI-RADS 1 | 0/15 (0%) | 15/15 (100%) | 18.01 | < 0.000 | 0.841 | < 0.000 | 18.01 | < 0.000 |
 NI-RADS 2 | 1/5 (20%) | 4/5 (80%) |  |  |  |  |  |  |
 NI-RADS 3 | 7/8 (87.5%) | 1/8 (12.5%) |  |  |  |  |  |  |
Total | 8/28 (28.6%) | 20/28 (71.4%) | Â | Â | Â | Â | Â | Â |
Combined primary and LN | Â | Â | 32.42 | < 0.000 | 0.763 | < 0.000 | 28.76 | < 0.000 |
 NI-RADS 1 | 1/25 (4%) | 24/25 (96%) |  |  |  |  |  |  |
 NI-RADS 2 | 3/15 (20%) | 12/15 (80%) |  |  |  |  |  |  |
 NI-RADS 3 | 14/16 (87.5%) | 2/16 (12.5%) |  |  |  |  |  |  |
Total | 18/56 (32.1%) | 38/56 (67.9%) | Â | Â | Â | Â | Â | Â |